We adapt Gaussian processes for estimating the average dose-response function in observational settings, introducing a powerful complement to treatment effect estimation for understanding heterogeneous effects. We incorporate samples from a Gaussian process posterior for the propensity score into a Gaussian process response model using Girard's approach to integrating over uncertainty in training data. We show Girard's method admits a positive-definite kernel, and provide theoretical justification by identifying it with an inner product of kernel mean embeddings. We demonstrate double robustness of our approach under a misspecified response function or propensity score. We characterize and mitigate regularization-induced confounding in Gaussian process response models. We show improvement over other methods for average dose-response function estimation in terms of coverage of the dose-response function and estimation bias, with less sensitivity to misspecification across experiments.
The relative value of interventional and observational samples in Bayesian Causal Linear Gaussian Models
Statistical Laboratory, Centre for Mathematical Sciences, University of Cambridge(剑桥大学数学科学中心统计实验室);Imperial College London(帝国理工学院);University of Oxford(牛津大学)
Permutation invariant multi-output Gaussian Processes for drug combination prediction in cancer
MRC Biostatistics Unit, University of Cambridge(剑桥大学医学研究委员会生物统计学单元);Oslo Centre for Biostatistics and Epidemiology (OCBE), University of Oslo(奥斯陆大学奥斯陆生物统计学与流行病学中心);Broad Institute of MIT & Harvard(麻省理工学院与哈佛大学博德研究所);CRUK Cambridge Centre Ovarian Programme(英国癌症研究剑桥中心卵巢项目);Cambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID)(剑桥治疗免疫学与传染病研究所)